Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for prevention of osteoporosis in ankylosing spondylitis
IRCT201212206975N3Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of alendronate in ankylosing spondylitis (AS), sponsored by Tabriz University of Medical Sciences. Started Feb 2013; status: completed.
02
Drugs
alendronate
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on IRCT201212206975N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201212206975N3.